WASHINGTON — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing hea...

ZURICH, Dec 8 (Reuters) - Swiss pharma group Roche's drug Perjeta significantly extended the lives of women with an aggressive and incurable form o...

By Ransdell Pierson Dec 5 (Reuters) - An experimental drug showed impressive effectiveness and safety in a mid-stage trial against a c...

July 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved Novartis AG's drug Afinitor to treat women with a certain t...

A new drug called T-DM1 appears to be relatively effective and safe for women with metastatic, Her2+ breast cancer, in itself and as compared to the standard XL regimen.

UPDATE: A Food and Drug Administration panel voted today to revoke Avastin's approval for treatment of breast cancer. The panel voted 6-0 to r...

WASHINGTON -- The best-selling cancer drug in the world comes under federal scrutiny once again this week, as drugmaker Roche makes a last-ditch effor...

CHICAGO — Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut ...

WASHINGTON — Follow-up studies of a Roche breast cancer drug showed that it failed to extend the lives of patients, federal health scientists sa...

Scientists have unlocked the secrets of the most widely-used breast cancer drug in a breakthrough that could save thousands of lives. Understanding h...